On March 5, 2025, the U.S. District Court for the Northern District of Texas denied the Outsourcing Facilities Association’s motion for a ...
Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.
Indianapolis-based Eli Lilly and Co. launched LillyDirect a little more than a year ago and has been ramping up efforts to ...
The makers of two popular weight-loss drugs—Wegovy and Zepbound—are cutting prices to make the medications more affordable for people without insurance. Novo Nordisk, the Danish company behind Wegovy, ...
FRIDAY, March 7, 2025 (HealthDay News) -- The makers of two popular weight-loss drugs — Wegovy and Zepbound — are cutting ...
Telehealth firms Teladoc and LifeMD said on Thursday they had signed an agreement to offer Eli Lilly's weight-loss drug ...
The home shipments — which will be fulfilled by CenterWell Pharmacy — include Wegovy injections of 0.25 mg, 0.5 mg, 1 mg, 1.7 ...
Offer only available to new and qualified returning subscribers. Cancel any time. Makers of the popular obesity treatments ...
Eli Lilly is seeking to further cement its stance as a leader in weight loss drugs in an ad campaign calling out “unapproved” medications.
Eli Lilly (LLY), the maker of the blockbuster weight-loss drug Zepbound, launched a new advertising campaign on Friday warning patients about off-brand versions of its treatments, saying “they put ...
The GLP-1 ad wars “Healthy Skepticism” comes weeks after Eli Lilly competitor and Ozempic-maker Novo Nordisk launched a print ...
Eli Lilly is airing an ad during the Academy Awards urging customers to adopt a health skepticism when marketed drug brands ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results